TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Polar Biomedicals AS
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
24,227
|
25,611
|
20,715 |
| Financial expenses |
294
|
17
|
11 |
| Earnings before taxes |
1,307
|
4,124
|
44 |
| Total assets |
12,982
|
10,994
|
8,141 |
| Current assets |
12,977
|
10,983
|
8,141 |
| Current liabilities |
4,942
|
4,176
|
4,445 |
| Equity capital |
8,040
|
6,818
|
3,695 |
| - share capital |
433
|
420
|
391 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
61.9%
|
62.0%
|
45.4% |
| Turnover per employee |
12,114
|
12,806
|
10,358 |
| Profit as a percentage of turnover |
5.4%
|
16.1%
|
0.2% |
| Return on assets (ROA) |
12.3%
|
37.7%
|
0.7% |
| Current ratio |
262.6%
|
263.0%
|
183.1% |
| Return on equity (ROE) |
16.3%
|
60.5%
|
1.2% |
| Change turnover |
-2,177
|
3,358
|
3,677 |
| Change turnover % |
-8%
|
15%
|
22% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.